Gonorrhea News and Research

RSS
Gonorrhea is a very common sexually transmitted disease (STD) caused by the bacteria Neisseria gonorrhea. It is estimated that 820,000 new cases of gonorrhea are diagnosed in the U.S. every year.

Gonorrhea is usually transmitted during vaginal, oral or anal sex or through sharing sex aids that have not been washed or covered with a condom each time they are used. A mother can also pass the infection onto her baby during childbirth, which can cause blindness in the infant.

Common symptoms in men include a burning sensation when urinating and a white, yellow, or green discharge from the penis, although some men may have no symptoms. Women with gonorrhea do not usually have any symptoms but initial symptoms may include pain or burning on urination, increased vaginal discharge, vaginal bleeding between periods and abdominal and pelvic pain.

If a woman is left untreated, infection can spread into the womb and fallopian tubes causing pelvic inflammatory disease which can lead to infertility and an increased risk for ectopic pregnancy. In men, the disease can cause epididymitis, a painful swelling in the back of the testicles that can also eventually lead to infertility.

Gonorrhea is identified using a urine test or swabs taken from a man’s urethra or a woman’s cervix. Antibiotics can be used to stop infection but cannot repair any permanent damage caused by the disease.
Study finds AFFIRM assay may accurately detect Trichamonos vaginalis

Study finds AFFIRM assay may accurately detect Trichamonos vaginalis

First evidence of human DNA fragment in bacterial genome

First evidence of human DNA fragment in bacterial genome

FIND, Cepheid collaborate to develop rapid molecular test for measurement of HIV viral load

FIND, Cepheid collaborate to develop rapid molecular test for measurement of HIV viral load

Abbott fourth quarter worldwide sales increase 13.4% to nearly $10 billion

Abbott fourth quarter worldwide sales increase 13.4% to nearly $10 billion

Study compares treatment cost of PID hospitalizations, ER care for teen girls

Study compares treatment cost of PID hospitalizations, ER care for teen girls

FDA clears first automated molecular tests to diagnose and differentiate HSV infection

FDA clears first automated molecular tests to diagnose and differentiate HSV infection

Gen-Probe submits PMA to FDA for APTIMA HPV assay to detect cervical cancer

Gen-Probe submits PMA to FDA for APTIMA HPV assay to detect cervical cancer

Gen-Probe third quarter research revenue increases 70% to $3.4 million

Gen-Probe third quarter research revenue increases 70% to $3.4 million

Abbott third quarter worldwide sales increase 11.8% to $8.7 billion

Abbott third quarter worldwide sales increase 11.8% to $8.7 billion

The state of sexually transmissible and blood-borne infections in Australia: the 2010 Surveillance Reports

The state of sexually transmissible and blood-borne infections in Australia: the 2010 Surveillance Reports

QIAGEN, Abbott enter agreement to strengthen testing menus for automated in-vitro diagnostic applications

QIAGEN, Abbott enter agreement to strengthen testing menus for automated in-vitro diagnostic applications

Gen-Probe submits 510(k) application to FDA for APTIMA Trichomonas vaginalis assay on TIGRIS system

Gen-Probe submits 510(k) application to FDA for APTIMA Trichomonas vaginalis assay on TIGRIS system

Condoms can prevent transmission of herpes simplex virus 2: Study

Condoms can prevent transmission of herpes simplex virus 2: Study

Abbott to commercialize Celera's CE-marked KIF6 genotyping assay outside U.S.

Abbott to commercialize Celera's CE-marked KIF6 genotyping assay outside U.S.

Safe sex campaign for over 50’s

Safe sex campaign for over 50’s

Abbott RealTime HBV assay receives marketing approval from FDA

Abbott RealTime HBV assay receives marketing approval from FDA

Advanced Life Sciences second-quarter net loss decreases to $2.1 million

Advanced Life Sciences second-quarter net loss decreases to $2.1 million

Gen-Probe second-quarter 2010 product sales up 14%

Gen-Probe second-quarter 2010 product sales up 14%

Abbot's innovative solutions to be highlighted at AACC

Abbot's innovative solutions to be highlighted at AACC

Abbott second-quarter global sales increase 17.8% to $8.8 billion

Abbott second-quarter global sales increase 17.8% to $8.8 billion

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.